New drug combo tested for women with spreading breast cancer
NCT ID NCT04681768
First seen Nov 01, 2025 · Last updated Apr 22, 2026 · Updated 31 times
Summary
This study tested whether adding the drug abemaciclib to standard hormone therapy helps women with advanced breast cancer that has spread to organs like the liver or lungs. The trial involved 95 women whose cancer couldn't be cured but could be managed. Researchers wanted to see if this combination could better control cancer growth and improve treatment response compared to hormone therapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde
Munich, 81675, Germany
Conditions
Explore the condition pages connected to this study.